Now live: Pro — the full 13F research suite for serious investorsSee pricing →
BOONE CAPITAL MANAGEMENT LLC

Q2 2023 · 13F-HR

BOONE CAPITAL MANAGEMENT LLCholdings as filed

Filed 2023-08-14 · accession 0001214659-23-011278

$278.6M
Reported value
13
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
91529Y106UNMUNUM GROUP$40.9M14.7%857,565CommonSOLE
60855R100MOHMOLINA HEALTHCARE INC$32.1M11.5%106,519CommonSOLE
071813109BAXBAXTER INTL INC$31.3M11.2%687,701CommonSOLE
125523100CITHE CIGNA GROUP$31.0M11.1%110,551CommonSOLE
194014502ENOVENOVIS CORPORATION$27.4M9.85%427,793CommonSOLE
235851102DHRDANAHER CORPORATION$26.4M9.47%109,910CommonSOLE
031162100AMGNAMGEN INC$18.5M6.65%83,499CommonSOLE
09062X103BIIBBIOGEN INC$17.9M6.43%62,877CommonSOLE
00287Y109ABBVABBVIE INC$11.9M4.26%88,026CommonSOLE
45166A102IDYAIDEAYA BIOSCIENCES INC$11.7M4.19%496,433CommonSOLE
74766Q101QTRXQUANTERIX CORP$11.3M4.06%501,144CommonSOLE
15678U128CERE1EURCEREVEL THERAPEUTICS HLDNG I$9.5M3.42%300,000CommonSOLE
205306103TBRGCOMPUTER PROGRAMS & SYS INC$8.6M3.10%349,245CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.